# Target-specific immunoPET Imaging of Digestive System Carcinoma

> **NCT06715839** · NA · RECRUITING · sponsor: **RenJi Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Malignancy
- Digestive Cancer
- Digestive System Neoplasm
- Digestive System Carcinoma
- Digestive System Cancer
- Liver Cancer
- Stomach Cancer
- Colon Cancer
- Rectum Cancer
- Pancreatic Cancer
- Esophagus Cancer
- Gallbladder Carcinoma
- Small Intestine Cancer
- Appendix Cancer
- Bile Duct Carcinoma

## Interventions

- **DRUG:** [68Ga]Ga-DOTA-H2D3
- **DRUG:** [18F]F-RESCA-RB14
- **DRUG:** [68Ga]Ga-NOTA-T4
- **DRUG:** [18F]F-RESCA-T4
- **DRUG:** [68Ga]Ga-NOTA-G5
- **DRUG:** [18F]F-RESCA-G5
- **DRUG:** [68Ga]Ga-NOTA-WWH347
- **DRUG:** [18F]F-RESCA-WWH347
- **DRUG:** [68Ga]Ga-NOTA-RND20
- **DRUG:** [18F]F-RESCA-RND20

## Key facts

- **NCT ID:** NCT06715839
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-04
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06715839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06715839, "Target-specific immunoPET Imaging of Digestive System Carcinoma". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT06715839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*